These results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assist the strategy of focusing on ACKR3 as a novel approach to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related Conditions. We independently investigation, assessment, and https://garryw603fdz4.techionblog.com/profile